Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Isaacs

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Nature Structural & Molecular Biology|July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.
Molecular Psychiatry|November 1, 2022
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A Albornoz, Alberto A Amarilla, Naphak Modhiran, et al.
NPJ Vaccines|July 23, 2025
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public healthRebecca K McLean, Miriam Pedrera, Nazia Thakur, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
Clinical & Translational Immunology|April 12, 2021
Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Danushka K Wijesundara, Naphak Modhiran, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Nature Structural & Molecular Biology|July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escapeAriel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.
Molecular Psychiatry|November 1, 2022
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A Albornoz, Alberto A Amarilla, Naphak Modhiran, et al.
NPJ Vaccines|July 23, 2025
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public healthRebecca K McLean, Miriam Pedrera, Nazia Thakur, et al.
Iscience|June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
Clinical & Translational Immunology|April 12, 2021
Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Danushka K Wijesundara, Naphak Modhiran, et al.
Pageof 3